mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif

You-Tong Wu1, Weiming Ouyang, Adam S Lazorchak

  • 1Department of Immunobiology and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

Insights

Akt phosphorylation at Ser-473 by mTORC2 targets the protein for degradation. This process, involving ubiquitination, acts as a negative feedback loop to terminate Akt signaling, crucial for cell growth and cancer.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Biochemistry

Background:

  • Akt (Protein Kinase B) is a key regulator of cell survival, growth, and proliferation.
  • Aberrant Akt activation is linked to human diseases, notably cancer.
  • mTORC2-dependent phosphorylation of Akt at Ser-473 is vital for full Akt activation.

Purpose of the Study:

  • To investigate the role of Akt Ser-473 phosphorylation beyond full Akt activation.
  • To elucidate the regulatory mechanisms controlling Akt protein stability and signaling duration.

Main Methods:

  • Investigated the impact of abolishing Akt Ser-473 phosphorylation on Akt stability.
  • Analyzed Akt ubiquitination and proteasomal degradation pathways.
  • Examined the effect of blocking proteasomal degradation on agonist-induced Akt activation.

Main Results:

  • Abolishing Akt Ser-473 phosphorylation stabilizes Akt after stimulation.
  • Akt Ser-473 phosphorylation promotes Lys-48-linked polyubiquitination, leading to proteasomal degradation.
  • Inhibiting proteasomal degradation extends agonist-induced Akt activation.

Conclusions:

  • mTORC2 regulates the Akt protein life cycle through both stabilization (turn motif) and degradation (hydrophobic motif phosphorylation).
  • Akt Ser-473 phosphorylation-dependent ubiquitination and degradation serve as a negative feedback mechanism to terminate Akt activation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...